Recent developments include Clover Health’s appointment of a permanent CFO, continued Medicare Advantage membership growth, and signaling of GAAP profitability in 2026. The company’s CMS Star Ratings improved for payment years 2027 and 2028, reflecting recognized plan quality. Earnings call transcripts provide detailed operational updates and strategic progress.

• Clover Health reported total revenues of $759.3 million and net income of $6.4 million for Q3 2026, driven by membership growth and higher premiums [N1].
• The company appointed a permanent CFO and reported third quarter 2026 results, highlighting operational progress [N2].
• CMS Star Ratings for Clover’s PPO and HMO Medicare Advantage plans were 4.5 Stars and 4.5 Stars respectively for payment year 2027, and 5 Stars and 4.5 Stars respectively for payment year 2028 [N3].
• Clover Health emphasized its PPO plans as flagship products with wide physician networks and competitive cost-sharing, supporting member choice and affordability [N4].
• The company’s AI-powered Clover Assistant platform continues to fuel Medicare Advantage growth and clinical decision-making improvements [N5][N6].
• Earnings call highlights underscore disciplined management of administrative expenses and strong liquidity position [N7].
• Legal developments including a favorable court judgment on Star Ratings have influenced CMS recalculations and payments [N8].

Clover Health’s technology-driven approach to Medicare Advantage plans leverages its proprietary Clover Assistant platform to improve clinical outcomes and plan economics. The platform’s integration with provider workflows and continuous learning cycle supports differentiated care management and cost control. Membership growth and expanding geographic footprint demonstrate market acceptance. The company’s ability to offer wide-network plans with competitive cost-sharing appeals to beneficiaries seeking provider choice and affordability. External commercialization through Counterpart Health could extend the platform’s reach and create new revenue streams. Strong CMS Star Ratings for its plans reflect recognized quality, which may support member retention and growth. Operational improvements and disciplined expense management have contributed to recent profitability milestones.

Clover Health faces risks related to regulatory changes in Medicare Advantage reimbursement and CMS Star Ratings, which impact plan revenues and bonuses. The company’s reliance on technology adoption by providers requires sustained engagement and investment. Competitive pressures from established insurers with larger scale and integrated provider networks may limit market penetration. The external commercialization of Clover Assistant is nascent and may not scale as anticipated. Operational execution risks include managing growth while controlling medical claims and administrative expenses. Changes in healthcare policy, reimbursement models, or adverse legal outcomes could materially affect financial results. The company’s remote-first structure may pose challenges in coordination and culture.

Clover Health’s moat is anchored in its proprietary Clover Assistant technology platform, which integrates extensive healthcare data sources and applies machine learning and AI to deliver personalized, actionable clinical insights at the point of care. This platform creates a closed feedback loop with providers, enabling continuous improvement and differentiation in clinical decision-making and care management. The company’s wide-network Medicare Advantage plans, emphasizing provider choice and affordability, differentiate it from competitors with narrower networks. Clover Health’s focus on traditionally underserved markets and complex chronic disease populations, supported by technology-enabled clinical programs, further strengthens its competitive position. The integration of Clover Assistant into major EHR systems enhances provider adoption and workflow integration, creating switching costs and barriers for competitors. Additionally, the external commercialization of its technology via Counterpart Health offers potential for scalable, high-margin revenue streams beyond insurance operations.

• Regulatory and Reimbursement Risk: Changes in Medicare Advantage reimbursement policies or CMS Star Ratings methodology could adversely affect Clover Health’s revenues and profitability.
• Technology Adoption Risk: Sustained provider engagement and adoption of Clover Assistant technology are critical; failure to maintain or grow usage could impair clinical and financial benefits.
• Competitive Risk: Competition from larger insurers with integrated provider networks and broader resources may limit Clover Health’s market share and growth.
• Operational Execution Risk: Managing rapid membership growth while controlling medical claims and administrative expenses presents execution challenges.
• Legal and Compliance Risk: Ongoing litigation and regulatory scrutiny, including appeals related to Star Ratings, could impact financial results and reputation.

• Clover Health operates Medicare Advantage (MA) Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans in five states and 203 counties as of September 30, 2026, with approximately 158,907 members.
• The company’s vision is to empower physicians with technology to identify, manage, and treat chronic diseases earlier, aiming for earlier diagnosis, treatment, and more affordable care.
• Clover Health’s proprietary software platform, Clover Assistant (externally licensed as Counterpart Assistant), is a cloud-based physician-enablement platform that aggregates data from over 100 sources to provide personalized, data-driven clinical insights at the point of care.
• Clover Assistant supports clinical decision-making by synthesizing longitudinal patient data, identifying quality gaps, disease burden, and providing actionable recommendations with evidence to providers.
• The platform integrates with major electronic health record (EHR) systems such as Epic, Cerner, and Athena to embed functionality into provider workflows.
• Clover Assistant is central to Clover Health’s strategy to improve care quality and plan performance, enabling providers to deliver better care and helping reduce medical claim expenses.
• The company operates clinical programs powered by Clover Assistant, including home-based care for high-acuity patients, supportive care, care transition support, and behavioral health coordination.
• Clover Health’s MA plans offer wide physician networks with open network designs, often providing the same cost-sharing for in-network and out-of-network primary care providers, emphasizing provider choice and affordability.
• The company launched Counterpart Health, a SaaS and tech-enabled services subsidiary, to commercialize Clover Assistant technology externally to payors and providers, though this remains a small part of overall business.
• Financial snapshot as of 2026-09-30 shows total revenues of $759.3 million for Q3 2026, a 53% increase year-over-year, driven by membership growth and higher premiums.
• Net income was $6.4 million for Q3 2026, compared to losses in prior-year periods, with adjusted EBITDA of $97.2 million for the nine months ended September 30, 2026, up from $45.0 million prior year.
• Insurance Benefits Expense Ratio (BER) was 91.1% for Q3 2026, improving from 93.5% in the prior year quarter, reflecting disciplined cost management.
• Liquidity ratios as of 2026-09-30 include a current ratio of 1.55 and a cash ratio of 0.23, with cash and equivalents of approximately $78.3 million.
• CMS Star Ratings for Clover Health’s PPO and HMO MA plans were 4.5 Stars and 4.5 Stars respectively for payment year 2027, with 5 Stars and 4.5 Stars respectively for payment year 2028, reflecting recognized plan quality.
• The company emphasizes serving traditionally underserved markets and Medicare eligible seniors with multiple chronic diseases, leveraging technology to scale care delivery in these areas.
• Recent developments include appointment of a permanent CFO and continued membership growth, with the company signaling GAAP profitability in 2026.
• The company’s strategy focuses on market selection, broad dissemination of Clover Assistant to providers, deploying best-in-class plans with strong unit economics, and expanding Counterpart Health’s external commercialization.
• Clover Health is a remote-first company without a physical headquarters, incorporated via a SPAC merger in 2021.
• The company uses non-GAAP financial measures such as Adjusted SG&A and Adjusted EBITDA to assess operational performance and trends.